FARMINGDALE, N.Y., Sept. 9 /PRNewswire/ — Misonix, Inc.
(Nasdaq:
MSON), a developer of state of the art, ultrasonic medical
device technology, which worldwide is used for acute health
conditions, has entered into a new, three year, exclusive
distribution agreement with Dismeval, s.l., based in
Valencia, Spain. Dismeval will sell and distribute the
SonaStar® Ultrasonic Surgical Aspirator and the
BoneScalpel™ Ultrasonic Bone Cutter throughout Spain,
Morocco, and Andorra. The agreement includes annual minimum
purchase requirements.
Dismeval specializes in introducing high tech, state-of-the-art
medical products to the Spanish and Moroccan markets and is well
known for their commitment to customer service. Dismeval’s clinical
emphasis is focused on Neuro, Spine, ENT, and Maxillo-facial
Surgery.
The SonaStar is used by Neuro and General Surgeons for quick and
efficient removal of both hard and soft tumors while sparing most
vessels. In addition, OsteoSculpt™ bone sculpting
technology can be employed with the SonaStar to safely remove
osseous structures, thus providing access to the surgical site.
The BoneScalpel is a tissue specific osteotomy device capable of
making precise cuts through bone and hard tissue while largely
preserving delicate soft tissue structures. It offers the
convenience and speed of a power instrument while minimizing the
peril associated with rotary sharps.
“Misonix is very pleased to add Dismeval to our growing family
of specialty distributors that are selling our OsteoSculpt and
SonaStar ultrasonic medical devices,” said Michael A. McManus, Jr.,
President and Chief Executive Officer of Misonix. “Their commitment
to service, as well as their success in introducing new medical
devices, was appealing to Misonix.”
About Misonix:Misonix, Inc. designs, develops, manufactures
and markets the
‘/>”/>
SOURCE
